Simone Bernardotto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Simone Bernardotto has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Margherita Morpurgo
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
6 shared publications Elisa Schiavon
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
3 shared publications- Martina Stocco
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
3 shared publications Annalisa Morelli
Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano, Italy
2 shared publicationsErica Franceschinis
2 shared publications- Giulia Yuri Moscatiello
Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano, Italy
2 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1467
Attack on Varroa: Wet Silica Gel Carriers for Controlled Thymol Release in Honey Bee Varroosis Control
Background: Rapid evaporation limits the use of volatile natural products for pest control. This study aimed to develop a wet sol–gel silica formulation for sustained delivery of thymol, a volatile natural acaricide used to control Varroa destructor in honeybee colonies. Methods: Co-solvents were screened for thymol solubilization and compatibility with the silica network. The optimized formulation was evaluated for physical stability under ambient conditions and thymol release at 33 °C. Field trials in naturally infested Apis mellifera colonies assessed acaricidal efficacy under different temperature conditions in comparison with a commercial thymol formulation. Results: Triacetin, a non-volatile co-solvent, enabled the preparation of a homogeneous wet silica gel containing 25% w/w thymol, with no phase separation or thymol crystallization for at least 28 days. At 33 °C, the formulation reduced thymol volatilization compared with free thymol. Release was proportional to the square root of time, consistent with a diffusion-controlled mechanism within the triacetin-filled silica network. Estimated thymol depletion times were 62.5 ± 3.4 days for the formulation and 24.6 ± 2.6 days for free thymol. In summer trials, a single administration of 12.5 g thymol per hive yielded acaricidal efficacy comparable to that of a commercial formulation administered twice, with no macroscopically detectable adverse effects on colony health. Performance was reduced under cooler conditions. Conclusions: Wet sol–gel silica prolonged thymol release and showed potential to reduce administration frequency under summer field conditions. Temperature-dependent performance highlights the need to match release kinetics to environmental conditions to maintain acaricidal exposure.
- 12 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1467
Open AccessAttack on Varroa: Wet Silica Gel Carriers for Controlled Thymol Release in Honey Bee Varroosis Control
Background: Rapid evaporation limits the use of volatile natural products for pest control. This study aimed to develop a wet sol–gel silica formulation for sustained delivery of thymol, a volatile natural acaricide used to control Varroa destructor in honeybee colonies. Methods: Co-solvents were screened for thymol solubilization and compatibility with the silica network. The optimized formulation was evaluated for physical stability under ambient conditions and thymol release at 33 °C. Field trials in naturally infested Apis mellifera colonies assessed acaricidal efficacy under different temperature conditions in comparison with a commercial thymol formulation. Results: Triacetin, a non-volatile co-solvent, enabled the preparation of a homogeneous wet silica gel containing 25% w/w thymol, with no phase separation or thymol crystallization for at least 28 days. At 33 °C, the formulation reduced thymol volatilization compared with free thymol. Release was proportional to the square root of time, consistent with a diffusion-controlled mechanism within the triacetin-filled silica network. Estimated thymol depletion times were 62.5 ± 3.4 days for the formulation and 24.6 ± 2.6 days for free thymol. In summer trials, a single administration of 12.5 g thymol per hive yielded acaricidal efficacy comparable to that of a commercial formulation administered twice, with no macroscopically detectable adverse effects on colony health. Performance was reduced under cooler conditions. Conclusions: Wet sol–gel silica prolonged thymol release and showed potential to reduce administration frequency under summer field conditions. Temperature-dependent performance highlights the need to match release kinetics to environmental conditions to maintain acaricidal exposure.
- Open Access
- 22 July 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 202, 119770
Steroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis
- 22 July 2026
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 202, 119770
Open AccessSteroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis
- Open Access
- 30 April 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 122
Boosting efficacy of natural acaricides using mesoporous nanoformulations: sustainable therapy against bee varroatosis
- 30 April 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 122
Open AccessBoosting efficacy of natural acaricides using mesoporous nanoformulations: sustainable therapy against bee varroatosis
- Open Access
- 21 May 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 110
Dissecting the contributions of composition and mesostructure on the release of thymol from silica-based mesopowders
- 21 May 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 110
Open AccessDissecting the contributions of composition and mesostructure on the release of thymol from silica-based mesopowders
- Open Access
- 16 November 2023
- Published by Elsevier in Biomaterials
- Vol. 303, 122394
Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly
- 16 November 2023
- Published by Elsevier in Biomaterials
- Vol. 303, 122394
Open AccessEfficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly
- Open Access
- 14 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1944
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo
Foot ulcerations are a disabling complication of diabetes and no treatment is currently available based on disease mechanisms. The protein serpin B3 (SB3) was identified as a positive biomarker of successful diabetic wound healing; therefore, its exogenous administration may promote healing. The topical administration of SB3 is challenging due to its protein nature. Physical entrapment in wet sol–gel silica can stabilize the protein’s conformation and permit its sustained delivery. However, irreversible syneresis and poor viscoelastic properties hamper wet sol–gel silica application as a semisolid vehicle. To overcome these limits, a sol–gel silica/hydroxypropylmethylcellulose (HPMC) hydrogel blend was developed. SB3 entrapped in 8% SiO2 wet sol–gel silica preserved its structure, was stabilized against denaturation, and was slowly released for at least three days. Blending a silica gel with an HPMC–glycerol (metolose-G) hydrogel permitted spreadability without affecting the protein’s release kinetics. When administered in vivo, SB3 in silica/metolose-G—but not in solution or in metolose-G alone—accelerated wound healing in SB3 knockout and diabetic mouse models. The results confirmed that SB3 is a new pharmacological option for the treatment of chronic ulcers, especially when formulated in a slow-releasing vehicle. Silica–metolose-G represents a novel type of semisolid dosage form which could also be applied for the formulation of other bioactive proteins.
- 14 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1944
Open AccessSemisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo
Foot ulcerations are a disabling complication of diabetes and no treatment is currently available based on disease mechanisms. The protein serpin B3 (SB3) was identified as a positive biomarker of successful diabetic wound healing; therefore, its exogenous administration may promote healing. The topical administration of SB3 is challenging due to its protein nature. Physical entrapment in wet sol–gel silica can stabilize the protein’s conformation and permit its sustained delivery. However, irreversible syneresis and poor viscoelastic properties hamper wet sol–gel silica application as a semisolid vehicle. To overcome these limits, a sol–gel silica/hydroxypropylmethylcellulose (HPMC) hydrogel blend was developed. SB3 entrapped in 8% SiO2 wet sol–gel silica preserved its structure, was stabilized against denaturation, and was slowly released for at least three days. Blending a silica gel with an HPMC–glycerol (metolose-G) hydrogel permitted spreadability without affecting the protein’s release kinetics. When administered in vivo, SB3 in silica/metolose-G—but not in solution or in metolose-G alone—accelerated wound healing in SB3 knockout and diabetic mouse models. The results confirmed that SB3 is a new pharmacological option for the treatment of chronic ulcers, especially when formulated in a slow-releasing vehicle. Silica–metolose-G represents a novel type of semisolid dosage form which could also be applied for the formulation of other bioactive proteins.